Oxford University researchers say their new anti-malaria vaccine proved highly effective
London, April 29 (RHC)-- Oxford University researchers say their new anti-malaria vaccine proved highly effective at preventing disease among children in a small clinical trial in West Africa.
The vaccine showed up to 77% efficacy in a study involving 450 toddlers in Burkina Faso, where malaria is endemic.
Oxford researcher Adrian Hill said it’s the first time a malaria vaccine has reached a goal set by the World Health Organization. He told reporters: “They want a malaria vaccine with 75% or more efficacy by 2030. We think we can do that. So, 77% is the highest yet and could really add to the existing tools that we use to control malaria.”
